JSM Activity #114

Back to main JSM 2001 Program page


Activity ID:  114
Title Room
Design Considerations for Phase I Clinical Trials H-Council/Cabinet
Date / Time Sponsor Type
08/06/2001    2:00 PM  -  3:50 PM ENAR Invited
Organizer: Anastasia Ivanova, University of North Carolina at Chapel Hill
Chair: Michael Schell, University of North Carolina at Chapel Hill
Discussant:  
Floor Discussion 3:45 PM
Description

A phase I study involves the first clinical application of a novel treatment. It is usually nonrandomized and is conducted to produce information concerning safety. Bayesian designs and random walks rules for phase I trials are considered.
  300198  By:  Anna Legedza 2:05 PM 08/06/2001
Successful Dosing in Phase I/II Trials

  300199  By:  Weng Kee Wong 2:30 PM 08/06/2001
Designs Incorporating Dropout Rates in a Phase 1

  300200  By:  Nancy Flournoy 2:55 PM 08/06/2001
Up-and-Down Designs for Dose-Finding

  300201  By:  Andre Rogatko 3:20 PM 08/06/2001
The Neverending Phase I Trial

JSM 2001

For information, contact meetings@amstat.org or phone (703) 684-1221.

If you have questions about the Continuing Education program, please contact the Education Department.

Revised March 2001